Bausch Health Companies Inc (BHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -564,000 | -182,000 | -209,000 | -212,000 | 198,000 |
| Depreciation Amortization | 986,000 | 657,000 | 330,000 | 1,493,000 | 1,120,000 |
| Income taxes - deferred | -33,000 | -30,000 | N/A | -176,000 | -195,000 |
| Accounts receivable | -176,000 | 55,000 | 108,000 | -57,000 | -26,000 |
| Accounts payable and accrued liabilities | 61,000 | -105,000 | -8,000 | -75,000 | -122,000 |
| Other Working Capital | -412,000 | -264,000 | -61,000 | -396,000 | -374,000 |
| Other Operating Activity | 780,000 | 229,000 | -6,000 | -1,305,000 | -1,804,000 |
| Operating Cash Flow | $642,000 | $360,000 | $154,000 | $-728,000 | $-1,203,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -31,000 | N/A | N/A | N/A |
| PPE Investments | -117,000 | -75,000 | -47,000 | -218,000 | -152,000 |
| Net Acquisitions | 5,000 | 1,000 | N/A | -40,000 | N/A |
| Purchase Of Investment | -13,000 | -11,000 | -44,000 | -17,000 | -15,000 |
| Sale Of Investment | 13,000 | 9,000 | 11,000 | 22,000 | 20,000 |
| Purchase Sale Intangibles | -11,000 | -7,000 | -4,000 | -50,000 | -20,000 |
| Other Investing Activity | -1,885,000 | -1,000 | 2,000 | -50,000 | -20,000 |
| Investing Cash Flow | $-1,997,000 | $-108,000 | $-78,000 | $-303,000 | $-167,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,145,000 | 455,000 | 155,000 | 6,836,000 | 6,481,000 |
| Debt Repayment | -1,507,000 | -690,000 | -279,000 | -7,846,000 | -7,224,000 |
| Common Stock Issued | N/A | N/A | N/A | 675,000 | 675,000 |
| Other Financing Activity | -84,000 | -27,000 | -18,000 | -139,000 | -130,000 |
| Financing Cash Flow | $1,554,000 | $-262,000 | $-142,000 | $-474,000 | $-198,000 |
| Exchange Rate Effect | -10,000 | 7,000 | 6,000 | -23,000 | -54,000 |
| Beginning Cash Position | 591,000 | 591,000 | 591,000 | 2,119,000 | 2,119,000 |
| End Cash Position | 780,000 | 588,000 | 531,000 | 591,000 | 497,000 |
| Net Cash Flow | $189,000 | $-3,000 | $-60,000 | $-1,528,000 | $-1,622,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 642,000 | 360,000 | 154,000 | -728,000 | -1,203,000 |
| Capital Expenditure | -117,000 | -75,000 | -47,000 | -218,000 | -152,000 |
| Free Cash Flow | 525,000 | 285,000 | 107,000 | -946,000 | -1,355,000 |